Conference
Abstract P4-22-19: Time on treatment of everolimus versus endocrine monotherapy or chemotherapy for early-line treatment of HR+/HER2- metastatic breast cancer: A retrospective chart review study in the US
Abstract
Abstract
Background:
Authors
Li N; Ohashi E; Koo V; Xie J; Hao Y; Tang D
Volume
77
Publisher
American Association for Cancer Research (AACR)
Publication Date
February 15, 2017
DOI
10.1158/1538-7445.sabcs16-p4-22-19
Conference proceedings
Cancer Research
Issue
4_Supplement
ISSN
0008-5472